Published in Pediatr Res on July 01, 2010
Niemann-Pick disease type C. Orphanet J Rare Dis (2010) 4.86
Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med (2010) 3.42
The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol (2012) 1.93
Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis (2013) 1.38
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease. Curr Top Med Chem (2014) 1.19
Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease. Sci Transl Med (2015) 1.14
Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C. J Neuropathol Exp Neurol (2012) 1.12
Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. Hum Mol Genet (2012) 1.10
A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations. Hum Mol Genet (2011) 1.10
Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream. J Lipid Res (2012) 1.07
Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling. J Lipid Res (2013) 1.07
Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-β-cyclodextrin. PLoS One (2012) 1.03
Membrane cholesterol modulates cochlear electromechanics. Pflugers Arch (2011) 1.00
Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin. J Lipid Res (2014) 0.96
Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1. J Inherit Metab Dis (2013) 0.91
Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease. Clin Lipidol (2012) 0.91
Development and validation of sensitive LC-MS/MS assays for quantification of HP-β-CD in human plasma and CSF. J Lipid Res (2014) 0.90
Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability. J Inherit Metab Dis (2013) 0.89
Efficacy and ototoxicity of different cyclodextrins in Niemann-Pick C disease. Ann Clin Transl Neurol (2016) 0.86
Electrodiagnostic testing and histopathologic changes confirm peripheral nervous system myelin abnormalities in the feline model of niemann-pick disease type C. J Neuropathol Exp Neurol (2013) 0.85
Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease. PLoS One (2013) 0.85
Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1). Hum Mol Genet (2014) 0.85
Corpus callosum diffusion tensor imaging and volume measures are associated with disease severity in pediatric Niemann-Pick disease type C1. Pediatr Neurol (2014) 0.84
Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1. Mol Genet Metab (2015) 0.83
Auditory phenotype of Niemann-Pick disease, type C1. Ear Hear (2013) 0.82
Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function. Clin Exp Pharmacol Physiol (2014) 0.80
Aging in the canine and feline brain. Vet Clin North Am Small Anim Pract (2014) 0.79
Outer Hair Cell Lateral Wall Structure Constrains the Mobility of Plasma Membrane Proteins. PLoS Genet (2015) 0.79
Olfactory deficits in Niemann-Pick type C1 (NPC1) disease. PLoS One (2013) 0.78
Hearing Loss and Otopathology Following Systemic and Intracerebroventricular Delivery of 2-Hydroxypropyl-Beta-Cyclodextrin. J Assoc Res Otolaryngol (2015) 0.78
Visual evoked potentials of Niemann-Pick type C1 mice reveal an impairment of the visual pathway that is rescued by 2-hydroxypropyl-ß-cyclodextrin. Orphanet J Rare Dis (2015) 0.77
Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-Pick disease, type C. J Assoc Res Otolaryngol (2014) 0.77
Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease. J Pharmacol Exp Ther (2016) 0.77
Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice. Int J Mol Sci (2016) 0.76
Localization and proteomic characterization of cholesterol-rich membrane microdomains in the inner ear. J Proteomics (2014) 0.76
Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases. Neurol Sci (2017) 0.76
Fostering collaborative research for rare genetic disease: the example of niemann-pick type C disease. Orphanet J Rare Dis (2016) 0.75
Effects of intracerebroventricular administration of 2-hydroxypropyl-β-cyclodextrin in a patient with Niemann-Pick Type C disease. Mol Genet Metab Rep (2014) 0.75
Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann-Pick type C disease-like HepG2 cells. Beilstein J Org Chem (2017) 0.75
Precision Medicine in Cats: Novel Niemann-Pick Type C1 Diagnosed by Whole-Genome Sequencing. J Vet Intern Med (2017) 0.75
Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1. Int J Mol Sci (2017) 0.75
Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease. Sci Rep (2017) 0.75
Niemann-Pick disease type C. Clin Genet (2003) 3.64
Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry (1995) 3.36
Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One (2009) 2.90
Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem (1989) 2.89
Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc Natl Acad Sci U S A (2009) 2.88
Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr Biol (2001) 2.22
Cyclodextrins. Toxicol Pathol (2008) 2.11
Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol (2001) 2.01
Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim Biophys Acta (2004) 2.00
2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food Chem Toxicol (2005) 1.89
Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid. J Lipid Res (2009) 1.87
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci (1997) 1.80
Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells. Proc Natl Acad Sci U S A (2009) 1.69
Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives. Life Sci (1988) 1.61
Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci (2001) 1.45
Mutation analysis of feline Niemann-Pick C1 disease. Mol Genet Metab (2003) 1.33
Feline sphingolipidosis resembling Niemann-Pick disease type C. Acta Neuropathol (1990) 1.18
GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol (1997) 1.13
Clinical, electrophysiological, and serum biochemical measures of progressive neurological and hepatic dysfunction in feline Niemann-Pick type C disease. Pediatr Res (2008) 1.13
Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. Biochem Pharmacol (2006) 1.10
Feline Niemann-Pick disease type C. Am J Pathol (1994) 1.04
Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier. J Pharmacol Exp Ther (2004) 1.03
Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy. J Neurochem (2006) 1.02
Effects of dietary cholesterol restriction in a feline model of Niemann-Pick type C disease. J Inherit Metab Dis (2001) 0.98
Neurological manifestations of Niemann-Pick disease type C in cats. J Vet Intern Med (1994) 0.96
Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins. J Pharmacol Exp Ther (2008) 0.92
Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles. J Pharm Sci (1994) 0.89
Hypocholesterolemic action of beta-cyclodextrin and its effects on cholesterol metabolism in pigs fed a cholesterol-enriched diet. J Lipid Res (1997) 0.84
Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method. Int J Pharm (2006) 0.81
Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. J Pharm Sci (1997) 0.79
Does ethics education influence the moral action of practicing nurses and social workers? Am J Bioeth (2008) 4.92
Ethical climate, ethics stress, and the job satisfaction of nurses and social workers in the United States. Soc Sci Med (2007) 1.72
Magnetic resonance imaging features of feline intracranial neoplasia: retrospective analysis of 46 cats. J Vet Intern Med (2004) 1.47
Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I. Sci Transl Med (2010) 1.38
Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression. Mol Genet Metab (2009) 1.25
Gene therapy for lysosomal storage diseases: the lessons and promise of animal models. J Gene Med (2004) 1.21
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease. Curr Top Med Chem (2014) 1.19
Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I. Mol Genet Metab (2010) 1.17
Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy. Mol Genet Metab (2008) 1.15
Clinical, electrophysiological, and serum biochemical measures of progressive neurological and hepatic dysfunction in feline Niemann-Pick type C disease. Pediatr Res (2008) 1.13
Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C. J Neuropathol Exp Neurol (2012) 1.12
A novel implanted device to wirelessly record and analyze continuous intracranial canine EEG. Epilepsy Res (2011) 1.10
Long-term amelioration of feline Mucopolysaccharidosis VI after AAV-mediated liver gene transfer. Mol Ther (2010) 1.06
Magnetic resonance spectroscopy of the occipital cortex and the cerebellar vermis distinguishes individual cats affected with alpha-mannosidosis from normal cats. NMR Biomed (2010) 1.00
A digital atlas of the dog brain. PLoS One (2012) 1.00
Does fear of retaliation deter requests for ethics consultation? Med Health Care Philos (2007) 0.96
Bone marrow transplantation for feline mucopolysaccharidosis I. Mol Genet Metab (2007) 0.95
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid. J Mass Spectrom (2012) 0.94
Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs. Mol Genet Metab (2012) 0.92
Comparative magnetic resonance imaging findings between gliomas and presumed cerebrovascular accidents in dogs. Vet Radiol Ultrasound (2011) 0.91
Electrodiagnostic testing and histopathologic changes confirm peripheral nervous system myelin abnormalities in the feline model of niemann-pick disease type C. J Neuropathol Exp Neurol (2013) 0.85
Everyday ethics: ethical issues and stress in nursing practice. J Adv Nurs (2010) 0.85
Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease. PLoS One (2013) 0.85
CT-guided stereotactic brain biopsy using the Kopf stereotactic system. Vet Radiol Ultrasound (2008) 0.84
Prevalence of diseases of the spinal cord of cats. J Vet Intern Med (2005) 0.84
Feline intracranial neoplasia: retrospective review of 160 cases (1985-2001). J Vet Intern Med (2003) 0.83
Identification of the rostral migratory stream in the canine and feline brain. PLoS One (2012) 0.83
Detection of a genetic mutation for myotonia congenita among Miniature Schnauzers and identification of a common carrier ancestor. Am J Vet Res (2002) 0.82
Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8. Hum Gene Ther (2013) 0.82
Central nervous system dysfunction associated with Rocky Mountain spotted fever infection in five dogs. J Am Anim Hosp Assoc (2005) 0.81
Signs of neurologic dysfunction in dogs with central versus peripheral vestibular disease. J Am Vet Med Assoc (2005) 0.81
Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis. J Neuropathol Exp Neurol (2014) 0.80
A review of gene therapy in canine and feline models of lysosomal storage disorders. Hum Gene Ther Clin Dev (2015) 0.79
Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs. Bone (2013) 0.79
Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs. J Bone Miner Res (2014) 0.78
Intravascular lymphoma involving the central and peripheral nervous systems in a dog. J Am Anim Hosp Assoc (2003) 0.78
Results of cerebrospinal fluid analysis, neurologic examination findings, and age at the onset of seizures as predictors for results of magnetic resonance imaging of the brain in dogs examined because of seizures: 115 cases (1992-2000). J Am Vet Med Assoc (2002) 0.77
In utero transplantation of monocytic cells in cats with alpha-mannosidosis. Transplantation (2009) 0.77
Clinical peripheral neuropathy associated with diabetes mellitus in 3 dogs. Can Vet J (2008) 0.75
Evaluation of the electroencephalogram in young cats. Am J Vet Res (2011) 0.75
Association of cauda equina compression on magnetic resonance images and clinical signs in dogs with degenerative lumbosacral stenosis. J Am Anim Hosp Assoc (2002) 0.75
Ventricular pneumocephalus and septic meningoencephalitis secondary to dorsal rhinotomy and nasal polypectomy in a dog. J Am Vet Med Assoc (2006) 0.75
Tumors affecting the spinal cord of cats: 85 cases (1980-2005). J Am Vet Med Assoc (2008) 0.75
Diffusion Tensor Imaging for Assessing Brain Gray and White Matter Abnormalities in a Feline Model of α-Mannosidosis. J Neuropathol Exp Neurol (2016) 0.75